Leading the delivery of a national pioneering genetic service to diagnose treatment for patients with cancer and rare diseases

Leading the delivery of a national pioneering genetic service to diagnose treatment for patients with cancer and rare diseases

Answer is working collaboratively with NHS England and Improvement to deliver a brand-new service which will help to identify effective treatments for patients with rare
genetic diseases (including intellectual disability) and cancer through a digital genomics platform. Working as a joint team, Answer are delivering:

  • assuring the development of the new national platform
  • managing all external suppliers and local NHS trusts, guiding the programme to ensure successful implementation
  • running clinical safety, information governance and technical assurance workstreamsas part the overall programme governance
  • managing and providing leadership for overall progress, including delivery of releases in line with national milestones and local NHS standards